# Angiogenic Markers in Cerebrovascular Disease (ANFIS)

> **NCT04240119** · — · ENROLLING_BY_INVITATION · sponsor: **Cedars-Sinai Medical Center** · enrollment: 300 (estimated)

## Conditions studied

- Stroke
- Transient Ischemic Attack
- Atherosclerosis
- Intracranial Arterial Stenosis
- Moyamoya

## Interventions

- **OTHER:** According to current clinical care standards

## Key facts

- **NCT ID:** NCT04240119
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2012-07
- **Primary completion:** 2030-07
- **Final completion:** 2030-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04240119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04240119, "Angiogenic Markers in Cerebrovascular Disease (ANFIS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04240119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*